Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ralph Lauren A | 19 | 0 | 2 | 0 | €167.84 | €179.60 | 7.004% |
| KeyCorp | 19 | 0 | 0 | 0 | €12.73 | €14.69 | 15.389% |
| Arch Capital Group | 19 | 0 | 2 | 0 | €93.87 | €99.47 | 5.962% |
| Moodys Corp. | 19 | 0 | 0 | 0 | €392.80 | €388.58 | -1.074% |
| G1 Therapeutics | 21 | 2 | 7 | 1 | €2.39 | €10.54 | 341.146% |
| Tyler Techs Inc. | 19 | 0 | 5 | 0 | €440.50 | €467.50 | 6.129% |
| Metlife Inc. | 19 | 0 | 1 | 0 | €65.05 | €76.33 | 17.346% |
| M/a-Com Technology Sol. | 19 | 0 | 0 | 0 | €100.00 | €106.58 | 6.582% |
| Taiwan Semiconductor Manufacturing Co. Ltd. ADR | 19 | 0 | 4 | 0 | €176.00 | €163.70 | -6.989% |
| Fiserv Inc. | 19 | 0 | 0 | 0 | €138.72 | €135.00 | -2.682% |
| Novo Nordisk A/S ADR | 20 | 1 | 5 | 0 | €132.00 | €144.02 | 9.105% |
| Citigroup Inc. | 22 | 3 | 1 | 0 | €56.63 | €71.90 | 26.972% |
| Cigna Corp. | 19 | 0 | 4 | 0 | €308.20 | €346.37 | 12.385% |
| Pacira Pharmaceuticals | 18 | 0 | 0 | 0 | €25.00 | €47.53 | 90.112% |
| LiveRamp Holdings, Inc. | 18 | 0 | 3 | 0 | €27.40 | €41.99 | 53.263% |
| Dexcom Inc. | 18 | 0 | 1 | 0 | €108.30 | €136.80 | 26.316% |
| Reinsurance Group America | 18 | 0 | 3 | 0 | €193.00 | €202.07 | 4.699% |
| Natural Alternat. | 19 | 1 | 2 | 0 | €5.65 | - | - |
| Abbott Laboratories | 18 | 0 | 2 | 0 | €97.74 | €116.48 | 19.174% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.09 | €26.01 | 29.449% |
| TechnipFMC PLC | 18 | 0 | 0 | 0 | €22.83 | €27.82 | 21.853% |
| Itron Inc. | 19 | 1 | 0 | 0 | €96.00 | €100.04 | 4.205% |
| Resmed Inc. | 18 | 0 | 1 | 0 | €196.45 | €203.18 | 3.424% |
| EyePoint Pharmaceuticals Inc. | 19 | 1 | 1 | 0 | €8.23 | €27.83 | 238.083% |
| Iovance Biotherapeutics Inc. | 21 | 3 | 2 | 0 | €7.49 | €26.24 | 250.280% |